Ipsos conducted the survey on behalf of U.S. Pharmacopeia, a global independent scientific organization, in September. It included 500 board-certified U.S. physicians who work or are affiliated with a hospital system or spend a portion of their time working in a hospital setting. The findings were published Feb. 3.
Four more findings:
1. Nearly all respondents, 95 percent, said they believe COVID-19 revealed medical supply chain vulnerabilities that aren’t going away. A similar proportion of 90 percent said they’re concerned the global medicines supply chain won’t be reliable during a crisis.
2. Eighty-three percent of physician respondents said they believe drug shortages have become a larger issue in recent years.
3. Physicians working in underserved communities were more likely (37 percent) to say drug shortages led to poor patient outcomes “often” or “sometimes,” compared to physicians (29 percent) in more resourced areas.
4. When asked who is responsible for maintaining a resilient medical supply chain physicians pointed to numerous stakeholders, including the federal government (92 percent), pharmaceutical companies (92 percent) and payers (79 percent.)
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.